Abstract
Tuberculosis caused by Mycobacterium tuberculosis has emerged as the biggest curse of our time causing significant morbidity and mortality. Increasing resistance in mycobacterium to existing drugs calls for exploration of metabolic pathways for finding novel drug targets and also for prioritization of known drug targets. Recent advances in molecular biology, bioinformatics and structural biology coupled with availability of M. tuberculosis genome sequence have provided much needed boost to drug discovery process. This review provides a glimpse of attractive drug targets for development of anti-mycobacterial drug development.
Keywords: Tuberculosis, Mycobacterium tuberculosis, multi-drug resistance, current therapy, novel drug targets, epidemiologists, anti-tubercular, para-aminosalicylic acid, host-pathogen, capreomycin, Mycobacterium, Isoniazid, dehydrogenases, menaquinone
Mini-Reviews in Medicinal Chemistry
Title: Targeting Tuberculosis: A Glimpse of Promising Drug Targets
Volume: 12 Issue: 3
Author(s): N. Arora and A. K. Banerjee
Affiliation:
Keywords: Tuberculosis, Mycobacterium tuberculosis, multi-drug resistance, current therapy, novel drug targets, epidemiologists, anti-tubercular, para-aminosalicylic acid, host-pathogen, capreomycin, Mycobacterium, Isoniazid, dehydrogenases, menaquinone
Abstract: Tuberculosis caused by Mycobacterium tuberculosis has emerged as the biggest curse of our time causing significant morbidity and mortality. Increasing resistance in mycobacterium to existing drugs calls for exploration of metabolic pathways for finding novel drug targets and also for prioritization of known drug targets. Recent advances in molecular biology, bioinformatics and structural biology coupled with availability of M. tuberculosis genome sequence have provided much needed boost to drug discovery process. This review provides a glimpse of attractive drug targets for development of anti-mycobacterial drug development.
Export Options
About this article
Cite this article as:
Arora N. and K. Banerjee A., Targeting Tuberculosis: A Glimpse of Promising Drug Targets, Mini-Reviews in Medicinal Chemistry 2012; 12 (3) . https://dx.doi.org/10.2174/1389557511209030187
DOI https://dx.doi.org/10.2174/1389557511209030187 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
Call for Papers in Thematic Issues
Bioprospecting of Natural Products as Sources of New Multitarget Therapies
According to the Convention on Biological Diversity, bioprospecting is the exploration of biodiversity and indigenous knowledge to develop commercially valuable products for pharmaceutical and other applications. Bioprospecting involves searching for useful organic compounds in plants, fungi, marine organisms, and microorganisms. Natural products traditionally constituted the primary source of more than ...read more
Computational Frontiers in Medicinal Chemistry
The thematic issue "Computational Frontiers in Medicinal Chemistry" provides a robust platform for delving into state-of-the-art computational methodologies and technologies that significantly propel advancements in medicinal chemistry. This edition seeks to amalgamate top-tier reviews spotlighting the latest trends and breakthroughs in the fusion of computational approaches, including artificial intelligence (AI) ...read more
Natural Products and Dietary Supplements in Alleviation of Metabolic, Cardiovascular, and Neurological Disorders
Metabolic disorders like diabetes, obesity, inflammation, oxidative stress, cancer etc, cardiovascular disorders like angina, myocardial infarction, congestive heart failure etc as well as neurological disorders like Alzheimer?s, Parkinson?s, Epilepsy, Depression, etc are the global burden. They covered the major segment of the diseases and disorders from which the human community ...read more
Natural Products in Drug Discovery
Natural products have always been one of the important ways of drug discovery due to their novel skeleton and diverse functional group characteristics. According to statistics, between 1981 and 2019, the FDA approved a total of 1,394 small molecule drugs for marketing, of which 930 marketed drugs originated from the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pharmacogenetics of Phase I and Phase II Drug Metabolism
Current Pharmaceutical Design Recent Studies of Antioxidant Quinoline Derivatives
Mini-Reviews in Medicinal Chemistry Nanotechnology Versus other Techniques in Improving Drug Dissolution
Current Pharmaceutical Design A 30-years Review on Pharmacokinetics of Antibiotics: Is the Right Time for Pharmacogenetics?
Current Drug Metabolism New Chalcones Containing Nucleosides Exhibiting In Vitro Anti-cancer Activities
Letters in Organic Chemistry [1, 2, 4]-Oxadiazoles: Synthesis and Biological Applications
Mini-Reviews in Medicinal Chemistry More Good News About Polymeric Plant- and Algae-Derived Biomaterials in Drug Delivery Systems
Current Drug Targets G-Protein Coupled Receptors (GPCRs): A Comprehensive Computational Perspective
Combinatorial Chemistry & High Throughput Screening Monocyte and Macrophage Dysfunction as a Cause of HIV-1 Induced Dysfunction of Innate Immunity
Current Molecular Medicine Recent Advances in Medicinal Chemistry to Treat Tuberculosis – Part-II
Current Topics in Medicinal Chemistry Pulmonary Drug Delivery System: A Novel Approach for Drug Delivery
Current Drug Therapy Antistaphylococcal Activity of Novel Salicylanilide Derivatives
Current Drug Discovery Technologies Macrolide Resistance in Mycobacteria
Medicinal Chemistry Reviews - Online (Discontinued) Reversal of Tumor Induced Dendritic Cell Paralysis: A Treatment Regimen Against Cancer
Current Immunology Reviews (Discontinued) The IL23/Th17 Pathway as a Therapeutic Target in Chronic Inflammatory Diseases
Inflammation & Allergy - Drug Targets (Discontinued) In Silico Appraisal, Synthesis, Antibacterial Screening and DNA Cleavage for 1,2,5-thiadiazole Derivative
Current Computer-Aided Drug Design Metabolite Concentration as a Criterion for Antibacterial Discovery
Current Computer-Aided Drug Design Patents Related to Pathogenic Human Coronaviruses
Recent Patents on Biotechnology Essential Oils with Microbicidal and Antibiofilm Activity
Current Pharmaceutical Biotechnology Henoch Schonlein Purpura in Childhood
Current Pediatric Reviews